TDAC
TDAC10.520USD
0.0000.00%
收盘 02/09, 16:00（美东）报价延迟15分钟
230.47M总市值
48.44市盈率 TTM
关于 Translational Development Acquisition Corp 公司
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
TDAC简介
公司代码TDAC
公司名称Translational Development Acquisition Corp
上市日期Dec 23, 2024
CEOHoffman (Michael B)
员工数量- -
证券类型Ordinary Share
年结日Dec 23
公司地址52 E 83Rd St.
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10028
电话14132042769
网址
公司代码TDAC
上市日期Dec 23, 2024
CEOHoffman (Michael B)
TDAC公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Wolverine Asset Management, LLC
7.93%
Magnetar Capital Partners LP
7.54%
AQR Capital Management, LLC
6.36%
LMR Partners LLP
4.64%
BMO Capital Markets (US)
4.64%
其他
68.90%
持股股东
持股股东
占比
Wolverine Asset Management, LLC
7.93%
Magnetar Capital Partners LP
7.54%
AQR Capital Management, LLC
6.36%
LMR Partners LLP
4.64%
BMO Capital Markets (US)
4.64%
其他
68.90%
股东类型
持股股东
占比
Hedge Fund
45.85%
Investment Advisor/Hedge Fund
31.60%
Research Firm
10.00%
Investment Advisor
3.99%
Pension Fund
1.16%
其他
7.40%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
50
15.97M
92.60%
+219.27K
2025Q3
44
14.91M
86.45%
+502.66K
2025Q2
33
13.81M
80.05%
+11.82M
2025Q1
31
12.89M
74.70%
+12.89M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wolverine Asset Management, LLC
1.56M
9.03%
+202.44K
+14.94%
Sep 30, 2025
Magnetar Capital Partners LP
1.30M
7.54%
--
--
Sep 30, 2025
AQR Capital Management, LLC
1.10M
6.36%
-3.00K
-0.27%
Sep 30, 2025
LMR Partners LLP
800.00K
4.64%
--
--
Sep 30, 2025
BMO Capital Markets (US)
800.00K
4.64%
-200.00K
-20.00%
Jun 30, 2025
Hudson Bay Capital Management LP
650.00K
3.77%
--
--
Sep 30, 2025
First Trust Capital Management L.P.
650.00K
3.77%
--
--
Sep 30, 2025
Tenor Capital Management Co., L.P.
635.40K
3.68%
--
--
Sep 30, 2025
Karpus Investment Management
616.77K
3.58%
--
--
Sep 30, 2025
Linden Advisors L.P.
600.00K
3.48%
--
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
CrossingBridge Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
